Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 per Share
Cycle Pharmaceuticals重申全現金提議,以每股8.00美元收購萬達生物製藥
Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 per Share
Cycle Pharmaceuticals重申全現金提議,以每股8.00美元收購萬達生物製藥
譯文內容由第三人軟體翻譯。